Showing results (551-560 of 673) with videos related to

Sort By:
Pageof 68
Hospital Pediatrics|October 26, 2022
Characteristics and Outcomes of Children Discharged With Nasoenteral Feeding TubesM Alex Ahearn, John R Stephens, Eric K Zwemer, et al.
Leukemia Research Reports|January 2, 2023
Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)Jumoke Okikiolu, Claire Woodley, Llywelyn Cadman-Davies, et al.
Obesity (Silver Spring, Md.)|August 13, 2011
Large size cells in the visceral adipose depot predict insulin resistance in the canine modelMorvarid Kabir, Darko Stefanovski, Isabel R Hsu, et al.
Journal of Neurology|October 16, 2019
ATP8A2-related disorders as recessive cerebellar ataxiaClaire Guissart, Alexander N Harrison, Mehdi Benkirane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2018
Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk FeaturesAnna L Godfrey, Peter J Campbell, Cathy MacLean, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 8, 2019
The effect of multiple recruitment contacts on response rates and patterns of missing data in a survey of bladder cancer survivors 6 months after cystectomyJoanna E Bulkley, Maureen O'Keeffe-Rosetti, Christopher S Wendel, et al.
Nature Communications|March 5, 2016
Commensurate antiferromagnetic excitations as a signature of the pseudogap in the tetragonal high-Tc cuprate HgBa2CuO(4+δ)M K Chan, C J Dorow, L Mangin-Thro, et al.
Blood|November 1, 2013
Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosisFrancisco Cervantes, Alessandro M Vannucchi, Jean-Jacques Kiladjian, et al.
Mayo Clinic Proceedings|December 17, 2021
Human Immunodeficiency Virus Infection and Variation in Heart Failure Risk by Age, Sex, and Ethnicity: The HIV HEART StudyAlan S Go, Kristi Reynolds, Harshith R Avula, et al.
Blood|May 4, 2011
The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patientsRobyn Scherber, Amylou C Dueck, Peter Johansson, et al.
Pageof 68